Primary Biliary Cholangitis clinical trials at UCLA

1 research study open to eligible people

Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis
open to eligible people ages 18 years and up
The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Biliary Cholangitis (PBC), and to assess the possible impact on the disease progression of PBC.
Los Angeles, California and other locations

Last updated: March 2, 2026